GlassScriptPhysician profile
Patrick Coffey
NPI 1174913917
$6,132.48
in general payments reported to CMS, 2019-2025
31 companies · $1,505 in 2025
The $1,505 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.86 · 2020: $70.04 · 2021: $778 · 2022: $746 · 2023: $2,346 · 2024: $672 · 2025: $1,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,247 · Travel and Lodging: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,246.63 |
| Travel and Lodging | $276.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $902.11 | 2020-2023 | Xarelto |
| Kerecis Limited | $860.74 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Surmodics, INC. | $726.45 | 2023-2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Medtronic, INC. | $444.51 | 2021-2025 | Venaseal, Symplicity G3, Abre |
| Boston Scientific Corporation | $408.96 | 2021-2025 | Ranger, Varithena Administration Pack, Eluvia |
| Philips North America LLC | $384.84 | 2021-2025 | (4066) Tack Endovascular Systems Atk, (6346) Intrasight Mobile, Affiniti 70 |
| W. L. Gore & Associates, INC. | $329.63 | 2022-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Endoprosthesis |
| Lemaitre Vascular, INC. | $291.80 | 2022-2025 | Hydro Lemaitre Valvulotome, Artegraft Vascular Graft, Restoreflow |
| Tactile Systems Technology INC | $267.86 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Bard Peripheral Vascular, INC. | $246.68 | 2021-2025 | Covera, Venovo, Vaccess |
| Cook Medical LLC | $241.08 | 2021-2025 | Cook, Zenith |
| Penumbra, INC. | $195.70 | 2022-2023 | Indigo System, Penumbra System |
| Bolton Medical INC | $162.77 | 2023-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Stryker Corporation | $105.28 | 2025 | Limflow System |
| Cordis US Corp. | $98.09 | 2021-2025 | Mynxgrip, Mynx Control |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $84.80 | 2021-2024 | Puraply |
| Smith+Nephew, INC. | $53.11 | 2024 | Grafix Pl, Grafix |
| Terumo Medical Corporation | $46.26 | 2021-2023 | Navicross |
| Kestra Medical Technology Services, INC. | $44.85 | 2025 | Assure Wcd |
| Argon Medical Devices, INC. | $41.71 | 2025 | Clot Management |
| Silk Road Medical, INC. | $32.44 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Polynovo North America LLC | $21.47 | 2023 | |
| Pfizer INC. | $19.30 | 2022 | |
| Imperative Care, INC | $18.92 | 2025 | Prodigy Catheter |
| Arjo INC. | $17.20 | 2025 | |
| Cashflow Solutions, LLC | $16.08 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Lundbeck LLC | $15.17 | 2020 | |
| Csl Behring | $14.86 | 2019 | |
| Teleflex LLC | $14.45 | 2025 | Manta |
| Astrazeneca Pharmaceuticals LP | $13.76 | 2024 | Farxiga |
| Molnlycke Health Care US, LLC | $11.60 | 2024 | Avance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Coffey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.